Cisatracurium Besylate 00409-1098-02

Package NDC

00409-1098-02

Manufacturer: Hospira, Inc.
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: March 17, 2020
Listing Expires: December 31, 2027
Application: ANDA203236

Need to source Cisatracurium Besylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Cisatracurium Besylate	2 mg/mL

Drug Class

Neuromuscular Nondepolarizing Blockade [PE]Nondepolarizing Neuromuscular Blocker [EPC]

Selected Package

00409-1098-02Selected

10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1098-02) / 5 mL in 1 VIAL, SINGLE-DOSE (0409-1098-12)